ASND icon

Ascendis Pharma
ASND

Overview Fund Trends Analyst Outlook Journalist POV

34 hedge funds and large institutions have $646M invested in Ascendis Pharma in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

3% less funds holding

Funds holding: 35 → 34 (-1)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18M
2
+$15.4M
3
+$12.7M
4
BBA
Baker Bros. Advisors
New York
+$11.1M
5
EAM
Eventide Asset Management
Massachusetts
+$10.9M

Top Sellers

1
-$14.2M
2
-$2.8M
3
-$2.6M
4
FCMI
Foresite Capital Management III
California
-$2.15M
5
EU
Emory University
Georgia
-$665K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$546K
27
$430K
28
$244K
29
$238K
30
$134K
31
$126K
32
$94K
33
$10K
34
$2K
35
–
36
–
37
–
38
–
39
–
40
–
1
2